基于单侧肘关节骨折后治疗期的当前临床病程的索赔。

IF 3 4区 医学 Q2 HEALTH CARE SCIENCES & SERVICES
Journal of Medical Economics Pub Date : 2025-12-01 Epub Date: 2025-06-19 DOI:10.1080/13696998.2025.2517499
Fernando Pena Molina, Maha Karim, Samantha J Beckley, Shaun K Stinton, Thomas P Branch
{"title":"基于单侧肘关节骨折后治疗期的当前临床病程的索赔。","authors":"Fernando Pena Molina, Maha Karim, Samantha J Beckley, Shaun K Stinton, Thomas P Branch","doi":"10.1080/13696998.2025.2517499","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>The aim of this paper was to determine a claims-based timeline of unilateral elbow fracture recovery including the effect of comorbidities and post-treatment complications on recovery.</p><p><strong>Methods: </strong>This study utilized data from the IBM MarketScan database (2015-2018) to assess costs and recovery timelines after unilateral elbow fracture treatment. All costs are reported in U.S. dollars and reflect prices during the 2015-2018 period. Costs examined included: (i) index surgery/treatment, (ii) complication surgery, (iii) revision or salvage surgeries, (iv) non-operative hospitalization, (v) motion restoring surgery and (vi) additional elbow-related outpatient surgery. Costs of related physician visits, physical/occupational therapy and diagnostic radiology were also incorporated. The impact of comorbidities-diabetes, obesity, peripheral vascular disease, and cardiovascular disease-was evaluated. Additionally, data on re-hospitalizations, with or without further surgery, were analyzed to understand complications after the initial treatment. Perioperative complications including joint fibrosis/contracture, infection, and pulmonary embolus were also reported.</p><p><strong>Results: </strong>Index surgery/treatment median cost and length of post-treatment recovery (from index surgery/treatment to last physical/occupational therapy claim) was $4,494 ($872-$10,444) and 102.5 days (36-480 days), respectively. A total of 59% of patients completed their post-treatment period in 6 months with 41% of patients taking longer. Patients who required a complication surgery had median recovery times and costs that increased three- and seven-fold, respectively, in comparison to those without complication surgeries. Comorbidities added 66-113 days to recovery. Peripheral and cardio-vascular disease coincided with 1.7-3 times higher post-treatment costs.</p><p><strong>Conclusion: </strong>Comorbidities and complications following elbow fracture treatment lead to substantial increases in both costs and recovery durations. Understanding the typical recovery timeline after elbow fracture treatment, as well as the variations in outlier patients, can assist in optimizing recovery management and guiding appropriate interventions.</p>","PeriodicalId":16229,"journal":{"name":"Journal of Medical Economics","volume":" ","pages":"934-943"},"PeriodicalIF":3.0000,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A claims-based current clinical course of the post-treatment period after a unilateral elbow fracture.\",\"authors\":\"Fernando Pena Molina, Maha Karim, Samantha J Beckley, Shaun K Stinton, Thomas P Branch\",\"doi\":\"10.1080/13696998.2025.2517499\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>The aim of this paper was to determine a claims-based timeline of unilateral elbow fracture recovery including the effect of comorbidities and post-treatment complications on recovery.</p><p><strong>Methods: </strong>This study utilized data from the IBM MarketScan database (2015-2018) to assess costs and recovery timelines after unilateral elbow fracture treatment. All costs are reported in U.S. dollars and reflect prices during the 2015-2018 period. Costs examined included: (i) index surgery/treatment, (ii) complication surgery, (iii) revision or salvage surgeries, (iv) non-operative hospitalization, (v) motion restoring surgery and (vi) additional elbow-related outpatient surgery. Costs of related physician visits, physical/occupational therapy and diagnostic radiology were also incorporated. The impact of comorbidities-diabetes, obesity, peripheral vascular disease, and cardiovascular disease-was evaluated. Additionally, data on re-hospitalizations, with or without further surgery, were analyzed to understand complications after the initial treatment. Perioperative complications including joint fibrosis/contracture, infection, and pulmonary embolus were also reported.</p><p><strong>Results: </strong>Index surgery/treatment median cost and length of post-treatment recovery (from index surgery/treatment to last physical/occupational therapy claim) was $4,494 ($872-$10,444) and 102.5 days (36-480 days), respectively. A total of 59% of patients completed their post-treatment period in 6 months with 41% of patients taking longer. Patients who required a complication surgery had median recovery times and costs that increased three- and seven-fold, respectively, in comparison to those without complication surgeries. Comorbidities added 66-113 days to recovery. Peripheral and cardio-vascular disease coincided with 1.7-3 times higher post-treatment costs.</p><p><strong>Conclusion: </strong>Comorbidities and complications following elbow fracture treatment lead to substantial increases in both costs and recovery durations. Understanding the typical recovery timeline after elbow fracture treatment, as well as the variations in outlier patients, can assist in optimizing recovery management and guiding appropriate interventions.</p>\",\"PeriodicalId\":16229,\"journal\":{\"name\":\"Journal of Medical Economics\",\"volume\":\" \",\"pages\":\"934-943\"},\"PeriodicalIF\":3.0000,\"publicationDate\":\"2025-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Medical Economics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/13696998.2025.2517499\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/6/19 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"HEALTH CARE SCIENCES & SERVICES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Medical Economics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/13696998.2025.2517499","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/6/19 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

摘要

目的:本文的目的是确定一个基于索赔的单侧肘关节骨折恢复时间表,包括合并症和治疗后并发症对恢复的影响。方法:本研究利用IBM MarketScan数据库(2015-2018)的数据来评估单侧肘关节骨折治疗后的成本和恢复时间。所有成本以美元报告,反映2015-2018年期间的价格。审查的费用包括:i)指数手术/治疗,ii)并发症手术,iii)翻修或挽救手术,iv)非手术住院,v)运动恢复手术和vi)额外的肘部相关门诊手术。相关医生就诊、物理/职业治疗和诊断放射的费用也被纳入其中。评估了合并症(糖尿病、肥胖、周围血管疾病和心血管疾病)的影响。此外,再住院的数据,有或没有进一步的手术,进行分析,以了解初始治疗后的并发症。围手术期并发症包括关节纤维化/挛缩、感染和肺栓塞也有报道。结果:指数手术/治疗的中位成本和治疗后恢复时间(从指数手术/治疗到最后一次物理/职业治疗索赔)分别为4,494美元(872- 10,444美元)和102.5天(36-480天)。总共59%的患者在6个月内完成了治疗后的疗程,41%的患者需要更长时间。与没有进行并发症手术的患者相比,需要并发症手术的患者的中位恢复时间和费用分别增加了3倍和7倍。合并症使康复时间延长66-113天。外周疾病和心血管疾病的治疗后费用高出1.7至3倍。结论:肘部骨折治疗后的合并症和并发症导致成本和恢复时间的大幅增加。了解肘部骨折治疗后典型的恢复时间,以及异常患者的变化,有助于优化恢复管理和指导适当的干预措施。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
A claims-based current clinical course of the post-treatment period after a unilateral elbow fracture.

Objective: The aim of this paper was to determine a claims-based timeline of unilateral elbow fracture recovery including the effect of comorbidities and post-treatment complications on recovery.

Methods: This study utilized data from the IBM MarketScan database (2015-2018) to assess costs and recovery timelines after unilateral elbow fracture treatment. All costs are reported in U.S. dollars and reflect prices during the 2015-2018 period. Costs examined included: (i) index surgery/treatment, (ii) complication surgery, (iii) revision or salvage surgeries, (iv) non-operative hospitalization, (v) motion restoring surgery and (vi) additional elbow-related outpatient surgery. Costs of related physician visits, physical/occupational therapy and diagnostic radiology were also incorporated. The impact of comorbidities-diabetes, obesity, peripheral vascular disease, and cardiovascular disease-was evaluated. Additionally, data on re-hospitalizations, with or without further surgery, were analyzed to understand complications after the initial treatment. Perioperative complications including joint fibrosis/contracture, infection, and pulmonary embolus were also reported.

Results: Index surgery/treatment median cost and length of post-treatment recovery (from index surgery/treatment to last physical/occupational therapy claim) was $4,494 ($872-$10,444) and 102.5 days (36-480 days), respectively. A total of 59% of patients completed their post-treatment period in 6 months with 41% of patients taking longer. Patients who required a complication surgery had median recovery times and costs that increased three- and seven-fold, respectively, in comparison to those without complication surgeries. Comorbidities added 66-113 days to recovery. Peripheral and cardio-vascular disease coincided with 1.7-3 times higher post-treatment costs.

Conclusion: Comorbidities and complications following elbow fracture treatment lead to substantial increases in both costs and recovery durations. Understanding the typical recovery timeline after elbow fracture treatment, as well as the variations in outlier patients, can assist in optimizing recovery management and guiding appropriate interventions.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of Medical Economics
Journal of Medical Economics HEALTH CARE SCIENCES & SERVICES-MEDICINE, GENERAL & INTERNAL
CiteScore
4.50
自引率
4.20%
发文量
122
期刊介绍: Journal of Medical Economics'' mission is to provide ethical, unbiased and rapid publication of quality content that is validated by rigorous peer review. The aim of Journal of Medical Economics is to serve the information needs of the pharmacoeconomics and healthcare research community, to help translate research advances into patient care and be a leader in transparency/disclosure by facilitating a collaborative and honest approach to publication. Journal of Medical Economics publishes high-quality economic assessments of novel therapeutic and device interventions for an international audience
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信